Concentriq AP-Dx logo

Concentriq AP-Dx

Digital pathology imaging and interpretation for primary diagnosis, enabling pathologists to view, analyze, and collaborate on whole slide images in clinical settings.

Solution by Proscia Inc.
Visit website

Overview

Concentriq AP-Dx is a comprehensive digital pathology software platform developed by Proscia, designed to support primary diagnosis in clinical settings of all sizes — from individual reference laboratories to large, multi-site hospital systems. The platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the purpose of primary diagnosis, and has been rated #1 by customers in the 2026 KLAS Digital Pathology rankings in both Europe and the United States, with 100% of surveyed customers stating they would buy again.

Built with a pathologist-centric design philosophy, Concentriq AP-Dx immerses pathologists in an intuitive experience for viewing, interpreting, sharing, and managing whole slide images. The platform is engineered to help labs transition confidently from glass slides to a fully digital diagnostic workflow, driving measurable gains in quality, efficiency, and readiness for future growth.

Core Capabilities

  • FDA 510(k)-cleared solution (K230839) for primary diagnosis in anatomic pathology
  • High-performance whole slide image viewer with tools designed to ease the transition from glass to digital
  • Real-time collaboration features enabling pathologists to share cases and broaden access to specialist expertise across sites
  • Robust interoperability to support large, multi-site organizations and integrate with existing laboratory infrastructure
  • Pathologist-centric workflows purpose-built for the modern anatomic pathology lab

AI-Powered Diagnostic Workflows

  • Deep integration with AI-powered diagnostic tools, enabling advanced computational pathology at scale
  • Demonstrated real-world impact in a feasibility study conducted with Quest Diagnostics and Ibex Medical Analytics, where AI-powered workflows allowed pathologists to sign out 2.9 cases per hour compared to 1.2 cases per hour without AI assistance
  • Supports the broader laboratory vision of embracing digitization and AI to overcome systemic challenges and advance precision medicine

Deployment and Professional Services

  • Suitable for clinical environments ranging from individual reference laboratories to the largest health systems
  • Proscia provides professional services alongside the software platform to support labs through every stage of their digital transformation
  • Positioned to support labs seeking to improve diagnostic quality, operational efficiency, and long-term scalability

Concentriq AP-Dx is part of the broader Concentriq Enterprise Pathology Platform offered by Proscia, which also includes an AI Portfolio and Proscia Aperture. The platform is designed for organizations committed to a digital and computational future in pathology, with a focus on interoperability, proven clinical workflows, and seamless integration of AI-driven capabilities.

Meta

Domain
Digital Pathology & Imaging
Subdomain
Digital Pathology Analysis
Software type(s)
Analytical Platform
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
Academic / ResearchBiotechCRODiagnostics / IVDPharma
Development stage(s)
Clinical
Target user(s)
Lab Manager / Core Facility ManagerClinical / Diagnostic Professional
Compliance standard(s)
21 CFR Part 11
Tag(s)
Uses AI